Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Tetra Therapeutics in May, 2018 for $952,592.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44MH107077-02A1 | Phase II | 952,592 | May 1, 2018 | |||||||
A STTR Phase I contract was awarded to Tetra Therapeutics in June, 2015 for $224,999.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41NS090666-01A1 | Phase I | 224,999 | June 1, 2015 | |||||||
A SBIR Phase I contract was awarded to Tetra Therapeutics in July, 2015 for $346,237.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43MH107077-01 | Phase I | 346,237 | July 1, 2015 | |||||||
A SBIR Phase II contract was awarded to Tetra Therapeutics in September, 2016 for $3,373,277.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44MH091791-06 | Phase II | 3,373,277 | September 20, 2016 | |||||||
A SBIR Phase II contract was awarded to Tetra Therapeutics in September, 2016 for $2,164,567.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44AG054243-01 | Phase II | 2,164,567 | September 15, 2016 | |||||||
A SBIR Phase II contract was awarded to Tetra Therapeutics for $3,003,708.0 USD from the U.S. Department of Health & Human Services. | SBIR | 2R44MH091791-03 | Phase II | 3,003,708 | ||||||||
A SBIR Phase I contract was awarded to Tetra Therapeutics for $698,827.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43MH091791-01 | Phase I | 698,827 |